KMB

From a fundamental perspective, Kimberly-Clark has shown a robust earnings per share (EPS) growth of 17.9% quarter-over-quarter, with an EPS of $5.17. However, revenue growth reveals a concerning trend, with a dramatic year-over-year decline of 1416.9%, despite a modest quarter-over-quarter revenue growth of 2.7%. The company maintains impressive gross and operating margins at 3560.6% and 1445.7%, respectively, alongside a return on equity (ROE) of 111.7%, demonstrating strong profitability. Analyst consensus leans toward a "BUY," with a target price of $114.67, suggesting potential upside, although the mixed ratings (3 strong buys, 3 buys, 9 holds, and 1 sell) indicate some caution among analysts regarding future performance.

Kimberly-Clark's next earnings report is not scheduled within the next 30 days, and the last quarter's results were released on March 31, 2026. Recent news includes significant share movement, with Diversified Trust Co selling 16,280 shares while Empyrean Capital Partners LP invested $18.89 million in the company, reflecting mixed sentiment. Additionally, Piper Sandler has raised the stock price target based on cost outlook, which could influence investor perceptions. As revenue growth remains a critical point of concern, stakeholders should closely monitor future earnings releases for signs of revenue stabilization and margin expansion, which will be crucial for the stock's trajectory moving forward.